Head-to-Head cancer drug showdown: which combo keeps myeloma at bay longer?
NCT ID NCT03729804
Summary
This study directly compares two different three-drug combinations for people newly diagnosed with multiple myeloma, a blood cancer. It aims to find out which treatment regimen is better at keeping the cancer from progressing and helps patients live longer without their disease getting worse. The trial involves 250 participants and measures how long the treatments work and how deeply they reduce remaining cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.